神经肌接头病重症肌无力LambertEaton综合征课件.ppt
《神经肌接头病重症肌无力LambertEaton综合征课件.ppt》由会员分享,可在线阅读,更多相关《神经肌接头病重症肌无力LambertEaton综合征课件.ppt(44页珍藏版)》请在三一办公上搜索。
1、神经肌接头病 (Disorders of neuromuscular transmission) 重症肌无力 Lambert-Eaton 综合征,Dep. of NeurologyThe 2nd Hospital Harbin Medical University,神经肌接头病 (Disorders of neuromusc,Neuromuscular Disorders Definition,The diseases of neuromuscular junction (NMJ) describes a sets of disease caused by circulating factor
2、s such as neurotoxins or autoantibodies which bind with high affinity to specific proteins at the NMJ and disturb the neuromuscular transmission.,Neuromuscular Disorders,Neuromusuclar Junction (NMJ) Physiology,the nerve AP reaches the nerve terminal which inflated and without myelin and leads to the
3、 opening of calcium channel and release of ACh into the synaptic cleft by exocytosis.,Neuromusuclar Junction (NMJ),Neuromusuclar Junction (NMJ) Physiology,1/3 of the ACh diffuses rapidly to the postsynaptic membrane and binds to the AChRs, leading to opening of the AChR-associated cation channel and
4、 depolarization called the end-plate potential (EPP). If the EPP exceeds certain threshold, voltage gated sodium channel at the postsynaptic membrane are opened. This generates the muscle action potential (CMAP) that propagates along the muscle fiber and activates contraction.,Neuromusuclar Junction
5、 (NMJ),Neuromusuclar Junction (NMJ) Physiology,Another 1/3 of the ACh is hydrolyzed by cholinesterase (ChE). The remaining 1/3 of the ACh is recaptured by the presynaptic membrane.,Neuromusuclar Junction (NMJ),重症肌无力 (Myasthenia Gravis, MG),概念病因及发病机制病理临床表现诊断及鉴别诊断治疗,重症肌无力 (Myasthenia Gravis, MG)概,Myas
6、thenia gravis (MG)Definition,MG was originated from Latin, meaning very severe weakness. acquired MG is an antibody and complement-mediated, T cell-dependent autoimmune disease leading to a defect in neuromuscular transmission.,Myasthenia gravis (MG)Definit,Myasthenia gravis ( MG) Epidemiology,It is
7、 the prototypic neuromuscular disorders with an incidence of 80-200 per million and prevalence about 500 per million. In China, it is estimated that 0.6 million people were diagnosed as MG and most of them lives in the South of China. It had been a life-threatening disease before 1970s, though nowad
8、ays the incidence of death has been greatly reduced to about 0.2%.,Myasthenia gravis ( MG) Ep,Myasthenia Gravis (MG)Etiology,The autoimmune origin of MG is proposed long before it was established in 1973 by the direct evidence provided by Patrick and Lindstrom, who have immunized rabbit with affinit
9、y-purified Torpedo AChR with CFA and reproduced the animal models representing human MG (EAMG).The AChR is the autoantigen.,Myasthenia Gravis (MG)Etiolog,Myasthenia Gravis (MG)Etiology,The presence of anti-AChR Abs can be demonstrated in 80%-90% of MG patients. There is a 3:1 female-male ratio for p
10、atients who develop MG in early adult life. Overall, the above makes MG fulfills the criteria for autoimmune diseases.,Myasthenia Gravis (MG)Etiolog,Myasthenia Gravis (MG)Etiology,Most of the patients with MG have abnormalities in the thymus, e.g. thymic hyperplastic or thymoma.Although the primary
11、antiself event being unclear, thymus appears to be the place where it initiates.The general opinion is that virus infection or other nonspecific factors invades the thymus in genetically predisposed individuals leading to the development of MG.,Myasthenia Gravis (MG)Etiolog,Myasthenia Gravis (MG)Pat
12、hology,Lymphoid folliculus can be seen in thymus. About 10% of MG patients has thymoma of epithelia type.Lymphorage, defined by aggregated lymphoid cells around the blood vessels, is sometimes seen in otherwise normal musculature in MG patients.,Myasthenia Gravis (MG)Patholo,Myasthenia Gravis (MG)Pa
13、thology,At the NMJ, grossly simplified postsynaptic folds with deposition of immune-complex and the anti-AChR Abs is demonstrated by immunochemical studies. There is also considerable debris within the widened synaptic cleft.Normal NMJ、NMJ in MG patients(示意图)(电镜),Myasthenia Gravis (MG)Patholo,Myasth
14、enia Gravis (MG)Clinical Manifestations,MG can arise at any age, although young females and old males are more vulnerable to it. Precipitating factors: concurrent infection, stress, weariness, menses, pregnancy or parturition. The disease initiates insidious and follows a slowly progressive course.,
15、Myasthenia Gravis (MG)Clinica,Myasthenia Gravis (MG)Clinical Manifestations,Clinically, MG features with fluctuated muscular weakness in intensity during the day and easy fatigability.Typically, the weakness varies in distribution and severity from day to day.Characterized by abnormal weakness, whic
16、h being worse at the end of the day or after exertion and tends to improve after rest or AChE treatment.,Myasthenia Gravis (MG)Clinica,Myasthenia Gravis (MG)Clinical Manifestations,The weakness often begins with the lateral or bilateral extra-ocular muscles, leading to asymmetric ocular palsies (e.g
17、. diplopia, strabismic) and ptosis.Pupillary responses are not affected.,Myasthenia Gravis (MG)Clinica,Myasthenia Gravis (MG)Clinical Manifestations,The patients may present with less wrinkles, amimia, difficulty in closing the eyes or disclosing tooth;difficulty in chewing or swallowing, nasal spee
18、ch;weakness of the neck or the proximal upper limbs.,Myasthenia Gravis (MG)Clinica,Myasthenia Gravis (MG)Crisisdefinition,Crisis describes a rapidly developed weakness in the bulbar muscles and respiratory insufficiency that necessitates assisted ventilation.It is the leading cause of death in patie
19、nts with MG.,Myasthenia Gravis (MG)Crisis,Myasthenia Gravis (MG)Crisisclassification,Myasthenic crisis: able to react to AChE drugs and being hypersensitive to the curare.Cholinergic crisis: 1. overmedication can lead to increased weakness, which, unlike myasthenic weakness, is unaffected or enhance
20、d by intravenous edrophonium. 2. It may be accompanied by pallor, sweating, nausea, vomiting, salivation, colic, and diarrhea (muscarinic syndrome). Brittie crisis: unresponsive to AChE.,Myasthenia Gravis (MG)Crisis,Myasthenia Gravis (MG)Osserman Classification,Five subgroups can be defined among pa
21、tients with myasthenia. I.Ocular IIa. Mild generalized IIb. Moderate generalized III. Progressively severe IV. late severe,Myasthenia Gravis (MG)Osserma,Myasthenia Gravis (MG)Other classification,MG can also be subdivided into adolescent and adult type, neonatal MG, congenital myasthenia, D-Penicill
- 配套讲稿:
如PPT文件的首页显示word图标,表示该PPT已包含配套word讲稿。双击word图标可打开word文档。
- 特殊限制:
部分文档作品中含有的国旗、国徽等图片,仅作为作品整体效果示例展示,禁止商用。设计者仅对作品中独创性部分享有著作权。
- 关 键 词:
- 神经 接头 重症 无力 LambertEaton 综合征 课件
![提示](https://www.31ppt.com/images/bang_tan.gif)
链接地址:https://www.31ppt.com/p-1440092.html